Lepu Medical: It is expected that the net profit will increase by 223.97%-385.95% in 2025 compared to the previous year.

LePu Medical announced that it is expected to achieve a net profit of 800 million to 1.2 billion yuan in 2025, with a year-on-year growth of 223.97% to 385.95%. During the reporting period, the company's core business in cardiovascular vascular intervention achieved steady growth in operating income, while the inventory clearance of the pharmaceutical sector's retail channels for preparation business was basically completed, leading to double-digit growth in operating income. The company's traditional business foundation remains solid, providing stable profits and cash flow. In addition, the company's strategic emerging sectors, including innovative drugs and dermatology business, contributed to the performance growth, with the net cash flow generated from operating activities increasing by approximately 95%.